We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDEX
3851
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$92K ﹤0.01%
488
+35
+8% +$7.95K
UBX
3852
DELISTED
Unity Biotechnology
UBX
$91K ﹤0.01%
+1,490
New +$105K
BDSI
3853
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$90K ﹤0.01%
21,559
+8,026
+59% +$34.3K
RMTI icon
3854
Rockwell Medical
RMTI
$28.4M
$89K ﹤0.01%
294
+2
+0.7% +$615
AVDL
3855
DELISTED
Avadel Pharmaceuticals
AVDL
$87K ﹤0.01%
20,804
-30,968
-60% -$77.5K
PSEC icon
3856
Prospect Capital
PSEC
$1.07B
$84K ﹤0.01%
+12,647
New +$83.4K
MAAS
3857
Maase Inc
MAAS
$7.87B
$81K ﹤0.01%
+207
New +$111K
LXRX icon
3858
Lexicon Pharmaceuticals
LXRX
$1.03B
$80K ﹤0.01%
26,349
-940
-3% -$2.91K
FET icon
3859
Forum Energy Technologies
FET
$708M
$78K ﹤0.01%
2,529
-13,790
-85% -$567K
MMLP icon
3860
Martin Midstream Partners
MMLP
$95.5M
$78K ﹤0.01%
17,047
+3,078
+22% +$15.8K
MYOV
3861
DELISTED
Myovant Sciences Ltd.
MYOV
$78K ﹤0.01%
14,884
+4,744
+47% +$35.2K
ACH
3862
Accendra Health
ACH
$237M
$77K ﹤0.01%
13,245
-231,387
-95% -$1.04M
CTST
3863
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$77K ﹤0.01%
68,690
+23,608
+52% +$52.9K
CECO icon
3864
Ceco Environmental
CECO
$3.85B
$76K ﹤0.01%
+10,982
New +$87.8K
VHC icon
3865
VirnetX Holding Corp
VHC
$54.4M
$76K ﹤0.01%
709
+199
+39% +$23.7K
WOW
3866
DELISTED
WideOpenWest
WOW
$75K ﹤0.01%
12,135
-21,275
-64% -$139K
CALX icon
3867
Calix
CALX
$2.26B
$73K ﹤0.01%
+11,487
New +$72.4K
YELL
3868
DELISTED
Yellow Corporation Common Stock
YELL
$73K ﹤0.01%
24,160
+1,216
+5% +$3.82K
CMRE icon
3869
Costamare
CMRE
$1.88B
$72K ﹤0.01%
+11,801
New +$68.1K
HMY icon
3870
Harmony Gold Mining
HMY
$9.84B
$71K ﹤0.01%
+24,825
New +$72.7K
NAT icon
3871
Nordic American Tanker
NAT
$1.38B
$71K ﹤0.01%
33,076
+9,119
+38% +$18.4K
ASXC
3872
DELISTED
Asensus Surgical, Inc.
ASXC
$70K ﹤0.01%
8,746
+1,054
+14% +$14.3K
BSMX
3873
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$70K ﹤0.01%
11,032
-28,568
-72% -$196K
DS
3874
DELISTED
Drive Shack Inc.
DS
$70K ﹤0.01%
16,427
+4,863
+42% +$22.9K
CEL
3875
DELISTED
Cellcom Israel, Ltd.
CEL
$70K ﹤0.01%
25,300

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.